BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2025.
World J Clin Cases. Nov 16, 2025; 13(32): 110553
Published online Nov 16, 2025. doi: 10.12998/wjcc.v13.i32.110553
Table 1 Demographic, laboratory, and clinical characteristics, n (%)
Variables
AC with ABP, n = 90
AC without ABP, n = 268
P value
Age in years73 (64-82)63 (52-75)0.305
Male sex52 (57.8)154 (57.5)0.958
Body temperature in °C37.4 (36.9-38.0)37.5 (36.9-38.4)0.797
WBC count as × 103/µL13.1 (9.2-17.3)10.4 (8.5-15.3)0.007
Abnormal WBC count55 (61.1)124 (42.3)0.015
AST in U/L178.5 (83-261)193 (111-468)0.722
ALT in U/L175 (89.5-290.5)222 (136-447)0.790
ALK-P in U/L215 (135.5-300.5)181 (123-267)0.316
Total bilirubin in mg/dL3.5 (2.1-5.3)3.6 (2.5-6.2)0.795
Creatinine in mg/dL1.08 (0.90-1.27)0.88 (0.73-1.15)0.201
Amylase1165 (611-2368)47.6 (40.0-69.4)< 0.01
Lipase2054 (1128-4289)28 (24-40)< 0.01
Blood culture performed, n = 29373 (81.1)220 (82.1)0.835
    Positive blood culture 14/73 (19.2)57/220 (25.9)0.245
Gallbladder status
    In situ with stone55 (61.1)156 (58.2)0.069
    In situ without stone28 (31.1)63 (23.5)0.152
    Post cholecystectomy7 (7.8)49 (18.3)0.018
CBDS on images before ERCP61 (67.8)171 (63.8)0.495
    Abdominal ultrasound, n = 891/19 (5.3)9/70 (12.9)0.353
    CT scan, n = 35658/90 (64.4)154/266 (57.9)0.274
MRCP, n = 193/4 (75)15/15 (100)0.047
Median CBDS diameter in mm5.6 (4.0-8.7)6.8 (4.7-10.0)0.775
Severity of AC
    Mild39 (43.3)141 (52.6)0.088
    Moderate28 (31.1)71 (26.5)0.397
    Severe23 (25.6)56 (20.9)0.356
Organ dysfunction
    Cardiovascular4 (4.4)12 (4.5)0.989
    Neurological6 (6.7)14 (5.2)0.606
    Respiratory6 (6.7)7 (2.6)0.075
    Renal11 (12.2)20 (7.5)0.165
    Hepatic4 (4.4)3 (1.1)0.044
    Hematological8 (8.9)16 (6.0)0.352


Write to the Help Desk